Early work on urine-derived EVs yielded transcript biomarkers such as mRNAs (GSTA1, CEBPA, PCBD1) and miRNAs (miR-126-3p, miR-449a) for ccRCC detection [37, 78]. This evidence concerns the gene CEBPA and nonpapillary renal cell carcinoma.